International Healthcare Company Bupa Proposed $22.8 Million Fine to Australia Federal Court to Resolve Case of Misleading Misrepresentations of Non-Entitled Healthcare Claims from 2018 to 2023, Had Already Paid $9.3 Million in Compensation to More than 4,100 Claims, Legal Action Against Bupa by Australian Competition & Consumer Commission
30th June | Hong Kong
International healthcare company Bupa has proposed a $22.8 million (AUD 35 million) fine to the Australia Federal Court to resolve the case of misleading misrepresentations of non-entitled healthcare claims from 2018 to 2023. Bupa had already paid $9.3 million (AUD 14.3 million) in compensation to more than 4,100 claims. The legal action against Bupa was taken by the Australian Competition & Consumer Commission (ACCC). Bupa – Established in 1947, Bupa’s purpose is helping people live longer, healthier, happier lives and making a better world. We are an international healthcare company serving over 60 million customers worldwide. With no shareholders, we reinvest profits into providing more and better healthcare for the benefit of current and future customers. Bupa has businesses around the world, principally in Australia, the UK, Spain, Poland, Chile, Hong Kong SAR, India, Türkiye, Brazil, Mexico and New Zealand. We also have associate businesses in Saudi Arabia. ACCC (30/6/25): “The ACCC has instituted proceedings in the Federal Court against Bupa HI Pty Ltd (Bupa) for breaches of the Australian Consumer Law in relation to members’ entitlements to private health insurance benefits for certain claims, affecting thousands of consumers over a period of more than five years. Bupa has admitted to engaging in misleading or deceptive conduct and making false or misleading representations by advising members they were not entitled to private health insurance benefits for their entire claim, when in fact this was not the case. Bupa has also admitted to engaging in unconscionable conduct in connection with its assessment of 388 Mixed Coverage Claims. Most of the claims impacted by the admitted conduct were claims for hospital treatment, in which two or more procedures were performed at the same time. In cases where part of the treatment was covered by a member’s policy and part of the treatment was not covered, Bupa incorrectly rejected the entire claim. The ACCC and Bupa will jointly ask the Court to order Bupa to pay a total penalty of $35 million and make other orders. It is a matter for the Court to determine whether the penalty and other orders are appropriate. Bupa started compensating affected members, medical providers and hospitals, before the start of this legal action, and to date, has paid $14.3 million to parties for more than 4,100 affected claims. The ACCC has accepted a court-enforceable undertaking from Bupa to continue compensating affected parties under its existing remediation program. Some consumers were left thousands of dollars out of pocket and had to personally finance expenses for some medical treatments that Bupa was in fact obliged to pay, at least in part, under its policies. Some policy holders also upgraded to more expensive policies to ensure coverage. In addition to financial impacts, some consumers were exposed to potential medical risks or complications, physical pain and distress as a result of not proceeding with medical treatment or as a result of undergoing multiple treatments after being falsely advised they were not covered for certain procedures … … Medical providers and hospitals were also impacted by the conduct, including by not receiving the payments to which they were entitled in respect of certain claims. Bupa has admitted that at various times between May 2018 and August 2023 it misrepresented that members were not entitled to any benefits for a Mixed Coverage Claim or Uncategorised Item Claim, when in fact, they were eligible for benefits for any treatment that was covered under their insurance policy. The misrepresentations occurred before medical treatment, when consumers were checking their coverage and entitlements with Bupa staff, as well as after a procedure due to its automatic claims assessment systems. Bupa also admitted that between June 2020 and February 2021, it stopped manually reviewing certain Mixed Coverage Claims that had been automatically incorrectly assessed as having no benefits payable. It has admitted that this was unconscionable in certain circumstances, including where it knew that manual review was necessary to ensure it identified and paid benefits for those claims. Bupa’s conduct occurred because Bupa staff did not have consistent and clear instructions and training for assessing Mixed Coverage Claims, and because its systems were programmed to incorrectly reject Mixed Coverage and Uncategorised Item Claims. A copy of the undertaking relating to the compensation is available at Bupa HI Pty Ltd. If you consider you may have been impacted by the conduct, please contact Bupa on a number you source independently or you can complete a Remediation Form available at: www.bupa.com.au/mixedcoverage(link is external). Bupa has cooperated with the ACCC during its investigation, including by agreeing to jointly seek declarations, penalties, an injunction, costs and other orders. The Federal Court will consider whether to make the orders sought on a date to be fixed.” Background – Bupa is one of the largest private health insurers in Australia. It is a subsidiary of Bupa HI Holdings Pty Ltd which is ultimately controlled by British United Provident Association Ltd. Mixed Coverage Claims are claims under Bupa’s private health insurance policy that included treatment that was covered under a member’s private health insurance policy as well as treatment that was not covered under their policy. Uncategorised Item Claims are claims that included treatment that were not assigned to a standard clinical category in Bupa’s claims assessment system.
“ International Healthcare Company Bupa Proposed $22.8 Million Fine to Australia Federal Court to Resolve Case of Misleading Misrepresentations of Non-Entitled Healthcare Claims from 2018 to 2023, Had Already Paid $9.3 Million in Compensation to More than 4,100 Claims, Legal Action Against Bupa by Australian Competition & Consumer Commission “
International Healthcare Company Bupa Proposed $22.8 Million Fine to Australia Federal Court to Resolve Case of Misleading Misrepresentations of Non-Entitled Healthcare Claims from 2018 to 2023, Had Already Paid $9.3 Million in Compensation to More than 4,100 Claims, Legal Action Against Bupa by Australian Competition & Consumer Commission
Sign Up / Register
Caproasia Users
- Manage $20 million to $3 billion of assets
- Invest $3 million to $300 million
- Advise institutions, billionaires, UHNWs & HNWs
Caproasia Platforms | 11,000 Investors & Advisors
- Caproasia.com
- Caproasia Access
- Caproasia Events
- The Financial Centre | Find Services
- Membership
- Family Office Circle
- Professional Investor Circle
- Investor Relations Network
Monthly Roundtable & Networking
Family Office Programs
The 2025 Investment Day
- March - Hong Kong
- March - Singapore
- July - Hong Kong
- July - Singapore
- Sept- Hong Kong
- Sept - Singapore
- Oct- Hong Kong
- Nov - Singapore
- Visit: The Investment Day | Register: Click here
Caproasia Summits
- The Institutional Investor Summit
- The Investment / Alternatives Summit
- The Private Wealth Summit
- The Family Office Summit
- The CEO & Entrepreneur Summit
- The Capital Markets Summit
- The ESG / Sustainable Investment Summit
